OMASS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
OMASS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Building 4000 John Smith Drive Oxford Business Park South Oxford OX4 2GX England
Full company profile for OMASS THERAPEUTICS LIMITED (10028228), an active life sciences and medical technology company based in Oxford, England. Incorporated 26 Feb 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2016–2024)
Cash in Bank
£49.30M
Net Assets
£55.14M
Total Liabilities
£4.04M
Turnover
N/A
Employees
60
Debt Ratio
7%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (9)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 5 | Nov 2018 | Series B, Series A |
| Investor 8 | Nov 2018 | Series A |
| Investor 9 | Feb 2020 | Series A |
See all 9 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Biller, Scott, Dr (phd) | Director | American | United States | 19 Apr 2022 | Active |
See all 19 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Syncona Limited
British Channel Islands
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Oxford Science Enterprises Holdings Ii Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Oxford Sciences Innovation Plc
Ceased 11 Sept 2018
Oxford Science Enterprises Holdings Ii Limited
Ceased 11 Sept 2018
Group Structure
Group Structure
Charges
Charges
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
4000 John Smith Drive, Oxford Business Park South, Oxford (OX4 2GX) OXFORD | Leasehold | - | 23 Mar 2023 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 24 Apr 2026 | Capital | Allotment of shares (GBP 90,146.612) on 23 Apr 2026 | |
| 22 Apr 2026 | Capital | Allotment of shares (GBP 90,146.612) on 16 Apr 2026 | |
| 11 Apr 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 24 Mar 2026 | Officers | Termination of James Arthur Geraghty as director on 17 Mar 2026 | |
| 21 Mar 2026 | Confirmation Statement | Confirmation statement made on 12 Mar 2026 with updates |
Allotment of shares (GBP 90,146.612) on 23 Apr 2026
Allotment of shares (GBP 90,146.612) on 16 Apr 2026
Annual accounts made up to 31 Dec 2025
Termination of James Arthur Geraghty as director on 17 Mar 2026
Confirmation statement made on 12 Mar 2026 with updates
Recent Activity
Latest Activity
Allotment of shares (GBP 90,146.612) on 23 Apr 2026
1 weeks ago on 24 Apr 2026
Allotment of shares (GBP 90,146.612) on 16 Apr 2026
1 weeks ago on 22 Apr 2026
Annual accounts made up to 31 Dec 2025
3 weeks ago on 11 Apr 2026
Termination of James Arthur Geraghty as director on 17 Mar 2026
1 months ago on 24 Mar 2026
Confirmation statement made on 12 Mar 2026 with updates
1 months ago on 21 Mar 2026